Figure 2From: MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1 Kaplan-Meier curves for patients with a p53 mutation showing that the time (months) to progression was significantly shorter for those with abnormal (blue curve) as compared to normal (green curve) p16 expression. (Log rank chi square 4.32, p = 0.038).Back to article page